EC50 (functional)
|
= 2.52 uM
|
PUBCHEM_BIOASSAY: Dose response for HTS for Beta-2AR agonists via FAP method from CP1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485366, AID492947, AID504448]
|
ChEMBL.
|
No reference
|
ED50 (functional)
|
= 1.25 mg kg-1
|
Effect of the compound in the social interaction behavioral test in mice
|
ChEMBL.
|
8893838
|
ED50 (functional)
|
= 1.25 mg kg-1
|
Effect of the compound in the social interaction behavioral test in mice
|
ChEMBL.
|
8893838
|
Ki (binding)
|
= 9.9 nM
|
Binding affinity at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes by [3H]-8-OH-DPAT displacement.
|
ChEMBL.
|
No reference
|
Ki (binding)
|
= 9.9 nM
|
Tested in vitro for binding affinity by measuring its ability to inhibit [3H]-8-OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes.
|
ChEMBL.
|
9171874
|
Ki (binding)
|
= 9.9 nM
|
Binding affinity towards rat 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT radioligand.
|
ChEMBL.
|
8893838
|
Ki (binding)
|
= 9.9 nM
|
Binding affinities against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in rat cerebral cortex membrane
|
ChEMBL.
|
9258372
|
Ki (binding)
|
= 9.9 nM
|
Binding affinity at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes by [3H]-8-OH-DPAT displacement.
|
ChEMBL.
|
No reference
|
Ki (binding)
|
= 9.9 nM
|
Tested in vitro for binding affinity by measuring its ability to inhibit [3H]-8-OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes.
|
ChEMBL.
|
9171874
|
Ki (binding)
|
= 9.9 nM
|
Binding affinity towards rat 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT radioligand.
|
ChEMBL.
|
8893838
|
Ki (binding)
|
= 9.9 nM
|
Binding affinities against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in rat cerebral cortex membrane
|
ChEMBL.
|
9258372
|
Ki (binding)
|
= 72.4 nM
|
Binding affinity at Alpha-1 adrenergic receptor in rat cerebral cortex membranes by [3H]-prazosin displacement.
|
ChEMBL.
|
No reference
|
Ki (binding)
|
= 72.4 nM
|
Tested in vitro for binding affinity by measuring its ability to inhibit [3H]-prazosin binding at alpha-1 adrenergic receptor in rat cerebral cortex membranes.
|
ChEMBL.
|
9171874
|
Ki (binding)
|
= 72.4 nM
|
Binding affinity towards alpha-1 adrenergic receptor using [3H]-prazosin radioligand.
|
ChEMBL.
|
8893838
|
Ki (binding)
|
= 72.4 nM
|
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]-prazosin as radioligand in rat cerebral cortex membrane
|
ChEMBL.
|
9258372
|
Ki (binding)
|
= 72.4 nM
|
Binding affinity at Alpha-1 adrenergic receptor in rat cerebral cortex membranes by [3H]-prazosin displacement.
|
ChEMBL.
|
No reference
|
Ki (binding)
|
= 72.4 nM
|
Tested in vitro for binding affinity by measuring its ability to inhibit [3H]-prazosin binding at alpha-1 adrenergic receptor in rat cerebral cortex membranes.
|
ChEMBL.
|
9171874
|
Ki (binding)
|
= 72.4 nM
|
Binding affinity towards alpha-1 adrenergic receptor using [3H]-prazosin radioligand.
|
ChEMBL.
|
8893838
|
Ki (binding)
|
= 72.4 nM
|
Binding affinities against Alpha-1 adrenergic receptor (alpha1 adrenoceptor) using [3H]-prazosin as radioligand in rat cerebral cortex membrane
|
ChEMBL.
|
9258372
|
Ki (binding)
|
= 90.6 nM
|
Binding affinity towards dopamine receptor D2 using [3H]-raclopride radioligand.
|
ChEMBL.
|
8893838
|
Ki (binding)
|
= 90.6 nM
|
Binding affinity towards dopamine receptor D2 using [3H]-raclopride radioligand.
|
ChEMBL.
|
8893838
|
Ki ratio (binding)
|
= 7.3
|
Selectivity ratio of serotonin and alpha receptor
|
ChEMBL.
|
9258372
|
Max effect (functional)
|
= 56.5 s
|
Effect of the compound in the social interaction behavioral test in mice
|
ChEMBL.
|
8893838
|
Max effect (functional)
|
= 56.5 s
|
Effect of the compound in the social interaction behavioral test in mice
|
ChEMBL.
|
8893838
|
Potency (functional)
|
0.3162 uM
|
PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory)
|
ChEMBL.
|
No reference
|
Potency (functional)
|
8.9125 uM
|
PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory)
|
ChEMBL.
|
No reference
|
Potency (functional)
|
29.0929 uM
|
PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory)
|
ChEMBL.
|
No reference
|
Potency (functional)
|
31.6228 uM
|
PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory)
|
ChEMBL.
|
No reference
|
Potency (functional)
|
44.6684 uM
|
PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory)
|
ChEMBL.
|
No reference
|
Potency (functional)
|
89.1251 uM
|
PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855]
|
ChEMBL.
|
No reference
|
T decrease (functional)
|
= -2.73 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 20 mg/kg sc.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -2.73 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 20 mg/kg sc.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -1.55 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 10 mg/kg sc.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -1.55 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 10 mg/kg sc.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -1.23 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 30 mg/kg po
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -1.23 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 30 mg/kg po
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -1 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 40 mg/kg po
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -1 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 40 mg/kg po
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -0.92 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 5 mg/kg sc.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -0.92 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 5 mg/kg sc.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -0.77 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 2.5 mg/kg sc.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -0.77 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 2.5 mg/kg sc.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -0.58 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 0.5 mg/kg sc.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -0.58 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 0.5 mg/kg sc.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -0.55 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 20 mg/kg po
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= -0.55 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 20 mg/kg po
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= 0.07 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 10 mg/kg po.
|
ChEMBL.
|
8893838
|
T decrease (functional)
|
= 0.07 degrees C
|
Effect of the compound on rectal temperature in mice at dose of 10 mg/kg po.
|
ChEMBL.
|
8893838
|